(Photo by Jeff Schear/Getty Images for Kennedy Forum)
July 1, 2020
Over the last decade, the addiction and mental health space has becoming increasingly digital – so much so that the first prescription digital therapeutic, Pear’s ReSET, scored FDA clearance nearly three years ago. While more and more players begin to join the so-called "DTx" space, the technology is yet to hit the mainstream radar, but a new coalition is looking to change that.
A list of high-...
June 30, 2020
OmniPEMF, a creator of wellness devices, has released its neurostimulation headband, called NeoRhythm, for worldwide availability today.
The headband uses pulsed electromagnetic field (PEMF) technology to help wearers create the desired mental state for sleep, relaxation, focus, pain relief, meditation or energy.
The PEMF technology in the headband triggers the brain to mimic the signals created...
June 29, 2020
Masimo, a medical technology company, announced today its device aimed at reducing the symptoms associated with opioid withdrawal.
The device, called Bridge, is a wearable, single-patient-use, percutaneous neurostimulator which is situated behind the ear. It applies electrical impulses to the cranial nerves around the ear, which can reduce neuron activity and reduce opioid withdrawal symptoms,...
June 29, 2020
Happify Health, known for its digital mental health programs, today released a platform targeted towards people with chronic conditions, called Kopa.
The first component of this new platform is Kopa for Psoriasis, a product created to provide resources and community for those living with the condition.
The company chose to first focus on psoriasis because of the comorbidities often associated...
June 29, 2020
Nordic digital therapeutics company SidekickHealth is partnering with pharma giant Pfizer to launch a digital therapeutics platform, in a deal thought to be worth more than $8 million.
The solution combines scientific expertise and digital technologies, giving patients a tool to help them maintain healthy lifestyles and improve their disease management and quality of life, while providing...
June 26, 2020
In the newest episode of HIMSSCast, MobiHealthNews founding editor Brian Dolan, now founder and lead writer at Exits and Outcomes, joins the host, Jonah Comstock, Managing Editor Laura Lovett and Associate Editor Dave Muoio for a bit of a post-mortem on Proteus Digital Health, the sensor-enabled pill company that filed for Chapter 11 bankruptcy protection last week.
More related to this...
June 23, 2020
Quit Genius, a digital addiction-recovery program, has extended its platform to support alcohol and opioid addictions.
The program is designed for enterprise and health plan customers in the U.S. to help their employees recover from addiction.
Fees are paid for by the user’s employer or health plan. Employers are charged an annual fee for each participant that actually enrolls in the program.
June 22, 2020
Singapore-headquartered digital health and data analytics company Holmusk announced that it is offering a new coaching program in Singapore which reaches out to severely overweight children, youths and parents in a convenient manner using a non face-to-face approach and guides them to make healthy lifestyle changes.
WHAT’S IT ABOUT
The coaching program is targeted at children and youths who are...
June 18, 2020
AARP Innovation Labs announced the winners of its Hacking Menopause Challenge, which aimed to create noninvasive tools to combat common menopause symptoms, such as hot flashes, fatigue and sleep disorders.
EloCare won the top prize of $5,000 for the best two-system solution. Pride Chill and NYX Systems each collected $4,000 for the best one-system solution and the best retail-directed one-system...
June 16, 2020
Proteus Digital Health, maker of an ingestible sensor for tracking medication adherence, filed for Chapter 11 bankruptcy protection yesterday.
The news comes months after word that the company had furloughed much of its staff, reassessed its high-profile partnership with Otsuka Pharmaceutical and shifted away from its primary focus area of mental disorder treatment.
The "smart pill" maker...